Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience
Tian, Shaozhou Ken, Killian, J Keith, Rekhtman, Natasha, Benayed, Ryma, Middha, Sumit, Ladanyi, Marc, Lin, Oscar, Arcila, Maria E
Published in Archives of pathology & laboratory medicine (1976) (01.11.2016)
Published in Archives of pathology & laboratory medicine (1976) (01.11.2016)
Get full text
Journal Article
Preclinical characterization of human Kallikrein 2 (hK2) as a novel target for the treatment of prostate cancer
Shen, Fei, Kelly, William Kevin, Pandit-Taskar, Neeta, McDevitt, Theresa, Smith, Ryan, Menard, Krista, Packman, Kathryn, Chaudhary, Ruchi, Rupnow, Brent, Yu, Margaret K., Guckert, Mary E., Tian, Shaozhou Ken, Chu, Gerald, Xie, Hong, Patricia, Daniel, Max, Steven I, Morris, Michael J.
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
SunRISe-4: TAR-200 plus cetrelimab or cetrelimab alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for or refuse neoadjuvant platinum-based chemotherapy
Psutka, Sarah P., Cutie, Christopher, Bhanvadia, Sumeet Kaur, Keegan, Kirk A., Crist, Wendy, Tian, Shaozhou Ken, Maffeo, John, Raybold, Bradley, Kashmer, Marietta, Hasan, Mohamad, Li, Xiang, Beeharry, Neil, Thomas, Shibu, Tian, Hui, Powles, Thomas
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Digital histopathology-based multimodal artificial intelligence scores predict risk of progression in a randomized phase III trial in patients with nonmetastatic castration-resistant prostate cancer
Feng, Felix Y, Smith, Matthew Raymond, Saad, Fred, Mobadersany, Pooya, Tian, Shaozhou Ken, Yip, Stephen S. F., Greshock, Joel, Khan, Najat, Yu, Margaret K., McCarthy, Sharon, Brookman-May, Sabine D., Todorovic, Tamara, Yamashita, Rikiya, Huang, Huei-Chung Rebecca, Showalter, Timothy N, Mitani, Akinori, Esteva, Andre, Small, Eric Jay
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
AI-enabled analysis of H&E-stained prostate cancer tissue images: Assessing risk for metastasis prior to apalutamide (APA) treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC)
Mobadersany, Pooya, Tian, Shaozhou Ken, Yip, Stephen S. F., Greshock, Joel, Khan, Najat, Yu, Margaret K., McCarthy, Sharon, Brookman-May, Sabine D., Muhammad, Hassan, Xie, Chensu, Huang, Wei, Basu, Hirak S, Wilding, George, Jain, Parag, Roy, Rajat, Small, Eric Jay, Saad, Fred, Smith, Matthew Raymond
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients (pts) with localized or locally advanced high-risk prostate cancer (PC)
Kibel, Adam S., Gleave, Martin, Brookman-May, Sabine D., Kim, Won, Evans, Christopher P., Efstathiou, Eleni, Kantoff, Philip W., Ross, Ashley, Shore, Neal D., Briganti, Alberto, Hadaschik, Boris A., Heidenreich, Axel, Rooney, Oliver Brendan, Tian, Shaozhou Ken, Wetherhold, Lisa, Xu, Weichun, Parsons, J. Kellogg, Yeruva, Kesav, Taplin, Mary-Ellen
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC)
Taplin, Mary-Ellen, Gleave, Martin, Evans, Christopher P., Efstathiou, Eleni, Kantoff, Philip W., Ross, Ashley, Shore, Neal D., Briganti, Alberto, Hadaschik, Boris A., Heidenreich, Axel, Rooney, Oliver Brendan, Tian, Shaozhou Ken, Wetherhold, Lisa, Xu, Weichun, Cheng, Shinta, Kibel, Adam S.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Computational pathological identification of prostate cancer following neoadjuvant treatment
Dogdas, Belma, Kanan, Christopher, Raciti, Patricia, Tian, Shaozhou Ken, Brookman-May, Sabine Doris, Wetherhold, Lisa, Smith, Andressa, Rooney, Oliver Brendan, McCarthy, Sharon Anne, Alvarez, John David, Lopez-Gitlitz, Angela, Casson, Adam, Godrich, Ran, Kunz, Jeremy D., Ceballos, Rodrigo, Leibowitz, Carla, Grady, Leo, Fuchs, Thomas J.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase III trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC)
Taplin, Mary-Ellen, Gleave, Martin, Evans, Christopher P., Efstathiou, Eleni, Kantoff, Philip W., Ross, Ashley, Shore, Neal D., Briganti, Alberto, Hadaschik, Boris A., Heidenreich, Axel, Rooney, Oliver Brendan, Tian, Shaozhou Ken, Wetherhold, Lisa, Xu, Weichun, Cheng, Shinta, Brookman-May, Sabine Doris, Lopez-Gitlitz, Angela, Kibel, Adam S.
Published in Journal of clinical oncology (20.02.2020)
Published in Journal of clinical oncology (20.02.2020)
Get full text
Journal Article
Abstract LB087: Characterization of JNJ-70218902, a TMEFF2 x CD3 bispecific antibody, in prostate cancer models
Basu, Subhasree, Russell, Mike, Sproesser, Katrin, Mattson, Bethany, Lowenstein, Cassandra L., Venkataramani, Sathya, Diamond, Maura, Ernst, Robin E., Jarantow, Stephen, Wong, Jackson, Chu, Gerald, Packman, Kathryn, Tian, Shaozhou Ken, Brodeur, Scott R., Yu, Margaret, Rupnow, Brent A.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
ERDAFITINIB FOR INTRAVESICAL ADMINISTRATION FOR USE IN THE TREATMENT OF BLADDER CANCER
GIESING, Dennis, DANIEL, Karen, BEEHARRY, Neil, HEYNS, Philip Erna H, TIAN, Shaozhou Ken, KIMPE, Kristof Leonard, MAMIDI, Srinivas, SMIRNOV, Denis A, PATEL, Jaymala, RAJPUROHIT, Yashoda Rani, DUBOIS, Kristof Johan W, DHONDT, Jens Julien Maurits Andre
Year of Publication 22.08.2024
Get full text
Year of Publication 22.08.2024
Patent
ERDAFITINIB FOR INTRAVESICAL ADMINISTRATION FOR USE IN THE TREATMENT OF BLADDER CANCER
GIESING, Dennis, DELAET, Urbain Alfons C, DANIEL, Karen, BEEHARRY, Neil, HEYNS, Philip Erna H, TIAN, Shaozhou Ken, DHONDT, Jens Julien Maurits André, MAMIDI, Srinivas, SMIRNOV, Denis A, PATEL, Jaymala, RAJPUROHIT, Yashoda Rani
Year of Publication 22.08.2024
Get full text
Year of Publication 22.08.2024
Patent